SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-029135
Filing Date
2022-08-11
Accepted
2022-08-11 16:26:56
Documents
59
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q hsto-10q_20220630.htm   iXBRL 10-Q 2538087
2 EX-31.1 hsto-ex311_8.htm EX-31.1 21112
3 EX-31.2 hsto-ex312_7.htm EX-31.2 21075
4 EX-32.1 hsto-ex321_6.htm EX-32.1 8443
5 EX-32.2 hsto-ex322_9.htm EX-32.2 8451
6 GRAPHIC gfvi41ncrev4000001.jpg GRAPHIC 116138
  Complete submission text file 0001564590-22-029135.txt   8910000

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA hsto-20220630.xsd EX-101.SCH 67809
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE hsto-20220630_cal.xml EX-101.CAL 55240
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hsto-20220630_def.xml EX-101.DEF 239680
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE hsto-20220630_lab.xml EX-101.LAB 527987
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hsto-20220630_pre.xml EX-101.PRE 391222
53 EXTRACTED XBRL INSTANCE DOCUMENT hsto-10q_20220630_htm.xml XML 1242195
Mailing Address 10655 SORRENTO VALLEY ROAD SUITE 200 San Diego CA 92121
Business Address 10655 SORRENTO VALLEY ROAD SUITE 200 San Diego CA 92121 (858) 526-3100
Histogen Inc. (Filer) CIK: 0001383701 (see all company filings)

IRS No.: 203183915 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36003 | Film No.: 221156274
SIC: 2834 Pharmaceutical Preparations